Navidea Biopharma (NAVB)

0.15 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/9/18 *Est.)

Latest Headlines

Navidea Biopharma (NAVB) Reports Patent Extension for Lymphoseek December 7, 2018 6:58 AM - StreetInsider Navidea Biopharmaceuticals Announces Patent Extension for Lymphoseek® December 7, 2018 6:55 AM - BizWire Form 8-K NAVIDEA BIOPHARMACEUTICA For: Nov 26 November 30, 2018 2:36 PM - SEC Filing Navidea Biopharma (NAVB) Announces Adam Cutler to Board November 29, 2018 4:38 PM - StreetInsider Navidea Biopharmaceuticals Appoints Adam Cutler to Board of Directors November 29, 2018 4:35 PM - BizWire Navidea Biopharma (NAVB) Appoints Dr. Michael Rosol as CMO November 29, 2018 4:31 PM - StreetInsider Navidea Biopharmaceuticals Appoints Dr. Michael Rosol as Chief Medical Officer November 29, 2018 4:30 PM - BizWire Form 8-K NAVIDEA BIOPHARMACEUTICA For: Nov 21 November 28, 2018 5:18 PM - SEC Filing Navidea Biopharmaceuticals to Present at the 11th Annual LD Micro Event 2018 November 28, 2018 6:55 AM - BizWire Navidea Biopharmaceuticals Announces Presentation at the Radiological Society of North America (RSNA) 104th Scientific Assembly and Annual Meeting 2018 November 27, 2018 6:55 AM - BizWire Navidea Biopharma (NAVB) Announces Dr. Kathy Rouan to Board November 26, 2018 4:34 PM - StreetInsider Navidea Biopharmaceuticals Appoints Dr. Kathy Rouan to Board of Directors November 26, 2018 4:30 PM - BizWire Form 10-Q NAVIDEA BIOPHARMACEUTICA For: Sep 30 November 9, 2018 2:48 PM - SEC Filing Form 8-K NAVIDEA BIOPHARMACEUTICA For: Nov 07 November 7, 2018 4:28 PM - SEC Filing Navidea Biopharmaceuticals Reports Third Quarter 2018 Financial Results November 7, 2018 4:10 PM - BizWire Navidea Biopharma (NAVB) Confirms it Won Platinum Litigation November 2, 2018 10:48 AM - StreetInsider Form 8-K NAVIDEA BIOPHARMACEUTICA For: Oct 30 November 2, 2018 10:39 AM - SEC Filing Navidea Biopharma (NAVB) Halted, News Pending November 2, 2018 10:28 AM - StreetInsider Navidea Biopharmaceuticals Schedules Third Quarter 2018 Earnings Conference Call and Business Update November 1, 2018 7:00 AM - BizWire Navidea Biopharmaceuticals Wins Dismissal of Platinum Litigation October 31, 2018 5:30 PM - BizWire Form 8-K NAVIDEA BIOPHARMACEUTICA For: Oct 25 October 30, 2018 4:53 PM - SEC Filing Navidea Biopharmaceuticals Receives Acceptance Letter from NYSE American October 30, 2018 4:30 PM - BizWire Navidea Biopharmaceuticals to Present Data on the Manocept Platform at 2018 ACR Annual Meeting October 11, 2018 6:55 AM - BizWire Form 8-K NAVIDEA BIOPHARMACEUTICA For: Oct 05 October 9, 2018 7:31 AM - SEC Filing Navidea Biopharmaceuticals to Present at the 2018 BIO Investor Forum October 8, 2018 5:00 PM - BizWire Form 8-K NAVIDEA BIOPHARMACEUTICA For: Oct 01 October 5, 2018 4:29 PM - SEC Filing Form 3 NAVIDEA BIOPHARMACEUTICA For: Sep 13 Filed by: Scott John K Jr. September 24, 2018 7:08 PM - SEC Filing Form SC 13G NAVIDEA BIOPHARMACEUTICA Filed by: Scott John K Jr. September 24, 2018 5:30 PM - SEC Filing Navidea Biopharmaceuticals Announces Acceptance into the National Institutes of Health Commercialization Accelerator Program September 17, 2018 5:30 PM - BizWire Form 8-K NAVIDEA BIOPHARMACEUTICA For: Sep 13 September 17, 2018 5:26 PM - SEC Filing Navidea Biopharmaceuticals Announces Closing of a $3 Million Private Placement September 17, 2018 5:21 PM - BizWire Full Article List